Predictors of progression to severe disease
| Univariate | ||
| OR (95% CI) | P value | |
| Age | 1.07 (1.04 to 1.1) | <0.001 |
| Males | 1.47 (0.3 to 1.54) | 0.357 |
| Hypertension | 5.36 (1.91 to 15.04) | 0.001 |
| Diabetes mellitus | 2.76 (0.88 to 8.69) | 0.083 |
| Cerebrovascular disease | 10.16 (1.14 to 90.6) | 0.038 |
| Smoking | 3.28 (0.74 to 14.61) | 0.119 |
| Use of ACEi/ARB | 2.82 (0.45 to 17.72) | 0.268 |
| Use of CCB | 4.28 (1.19 to 15.36) | 0.026 |
| WBC | 1.07 (0.93 to 1.24) | 0.334 |
| CRP | 1.02 (1.01 to 1.04) | 0.003 |
| eGFR | 0.97 (0.95 to 0.99) | 0.001 |
| Log NT-proBNP | 2.80 (1.74 to 4.52) | <0.001 |
| Log hs-TnT | 6.63 (2.24 to 19.65) | 0.001 |
| Pulmonary lesion ratio | 1.10 (1.07 to 1.15) | <0.001 |
ACEi, ACE inhibitor; ARB, angiotensin II receptor blocker; CCB, calcium channel blocker; CRP, C reactive protein; eGFR, estimated glomerular filtration rate; hs-TnT, high-sensitivity troponin T; NT-proBNP, N-terminal-proB-type natriuretic peptide; WBC, white blood cell count.